1. Home
  2. CPAC vs CGEM Comparison

CPAC vs CGEM Comparison

Compare CPAC & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPAC
  • CGEM
  • Stock Information
  • Founded
  • CPAC 1949
  • CGEM 2016
  • Country
  • CPAC Peru
  • CGEM United States
  • Employees
  • CPAC N/A
  • CGEM N/A
  • Industry
  • CPAC Building Materials
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPAC Industrials
  • CGEM Health Care
  • Exchange
  • CPAC Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • CPAC 497.5M
  • CGEM 506.1M
  • IPO Year
  • CPAC 2012
  • CGEM 2021
  • Fundamental
  • Price
  • CPAC $5.81
  • CGEM $7.31
  • Analyst Decision
  • CPAC Sell
  • CGEM Strong Buy
  • Analyst Count
  • CPAC 1
  • CGEM 8
  • Target Price
  • CPAC $6.00
  • CGEM $32.86
  • AVG Volume (30 Days)
  • CPAC 3.2K
  • CGEM 419.9K
  • Earning Date
  • CPAC 04-28-2025
  • CGEM 05-14-2025
  • Dividend Yield
  • CPAC 8.63%
  • CGEM N/A
  • EPS Growth
  • CPAC 17.75
  • CGEM N/A
  • EPS
  • CPAC 0.12
  • CGEM N/A
  • Revenue
  • CPAC $524,464,683.00
  • CGEM N/A
  • Revenue This Year
  • CPAC N/A
  • CGEM N/A
  • Revenue Next Year
  • CPAC N/A
  • CGEM $278.37
  • P/E Ratio
  • CPAC $9.48
  • CGEM N/A
  • Revenue Growth
  • CPAC 1.44
  • CGEM N/A
  • 52 Week Low
  • CPAC $5.10
  • CGEM $7.27
  • 52 Week High
  • CPAC $6.65
  • CGEM $30.19
  • Technical
  • Relative Strength Index (RSI)
  • CPAC 53.23
  • CGEM 32.53
  • Support Level
  • CPAC $5.80
  • CGEM $7.27
  • Resistance Level
  • CPAC $5.95
  • CGEM $7.85
  • Average True Range (ATR)
  • CPAC 0.02
  • CGEM 0.43
  • MACD
  • CPAC 0.00
  • CGEM -0.07
  • Stochastic Oscillator
  • CPAC 90.60
  • CGEM 11.22

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: